Crescent Biopharma (CBIO) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2024)
Crescent Biopharma (CBIO) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Crescent Biopharma |
486.92 Mn |
297.76 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
21.43% |
| Sep 30, 2024 |
-7.14% |
| Jun 30, 2024 |
-23.08% |
| Mar 31, 2024 |
76.47% |
| Dec 31, 2023 |
26.32% |
| Sep 30, 2023 |
12.50% |
| Jun 30, 2023 |
48.00% |
| Mar 31, 2023 |
39.29% |
| Dec 31, 2022 |
42.42% |
| Sep 30, 2022 |
52.94% |
| Jun 30, 2022 |
10.71% |
| Mar 31, 2022 |
0.00% |
| Dec 31, 2021 |
3.05% |
| Dec 31, 2020 |
0.02% |
| Jun 30, 2016 |
-180.39% |
| Dec 31, 2015 |
-20.51% |
| Sep 30, 2015 |
-8.57% |
| Jun 30, 2015 |
30.77% |
| Mar 31, 2015 |
-23.33% |
| Dec 31, 2014 |
86.07% |
